Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
Fuji
Cipla
Daiichi Sankyo
AstraZeneca
QuintilesIMS
Medtronic
Fish and Richardson

Generated: June 21, 2018

DrugPatentWatch Database Preview

Angelini Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for ANGELINI PHARMA, and what generic alternatives to ANGELINI PHARMA drugs are available?

ANGELINI PHARMA has one approved drug.

There are three US patents protecting ANGELINI PHARMA drugs.

There are ninety-four patent family members on ANGELINI PHARMA drugs in thirty-three countries.

Summary for Angelini Pharma
International Patents:94
US Patents:3
Tradenames:1
Ingredients:1
NDAs:1
Patent Litigation for Angelini Pharma: See patent lawsuits for Angelini Pharma

Drugs and US Patents for Angelini Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Angelini Pharma OLEPTRO trazodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022411-002 Feb 2, 2010 DISCN Yes No 6,607,748 ➤ Sign Up Y ➤ Sign Up
Angelini Pharma OLEPTRO trazodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022411-002 Feb 2, 2010 DISCN Yes No 8,133,893 ➤ Sign Up Y Y ➤ Sign Up
Angelini Pharma OLEPTRO trazodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022411-001 Feb 2, 2010 DISCN Yes No 6,607,748 ➤ Sign Up Y ➤ Sign Up
Angelini Pharma OLEPTRO trazodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022411-001 Feb 2, 2010 DISCN Yes No 8,133,893 ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ANGELINI PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Tablets 150 mg and 300 mg ➤ Subscribe 2010-10-18

Non-Orange Book US Patents for Angelini Pharma

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,439,866 Trazodone composition for once a day administration ➤ Sign Up
8,414,919 Sustained drug release composition ➤ Sign Up
8,314,236 Trazodone and trazodone hydrochloride in purified form ➤ Sign Up
8,962,019 Sustained drug release composition ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Dow
Federal Trade Commission
McKesson
Deloitte
UBS
Johnson and Johnson
Cerilliant
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.